367 related articles for article (PubMed ID: 15354741)
41. Immunoprofile of mucinous non-neoplastic cyst of the pancreas.
Zhu B; Lin X
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):265-70. PubMed ID: 22820665
[TBL] [Abstract][Full Text] [Related]
42. Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study.
Postlewait LM; Ethun CG; McInnis MR; Merchant N; Parikh A; Idrees K; Isom CA; Hawkins W; Fields RC; Strand M; Weber SM; Cho CS; Salem A; Martin RC; Scoggins C; Bentrem D; Kim HJ; Carr J; Ahmad S; Abbott DE; Wilson GC; Kooby DA; Maithel SK
JAMA Surg; 2017 Jan; 152(1):19-25. PubMed ID: 27760255
[TBL] [Abstract][Full Text] [Related]
43. Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas--with an implication for their roles in tumorigenesis.
Liu H; Shi J; Wang HL; Zhang J; Brown RE; Wilkerson M; Lin F
Ann Clin Lab Sci; 2012; 42(2):109-17. PubMed ID: 22585604
[TBL] [Abstract][Full Text] [Related]
44. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature.
Nilsson LN; Keane MG; Shamali A; Millastre Bocos J; Marijinissen van Zanten M; Antila A; Verdejo Gil C; Del Chiaro M; Laukkarinen J
Pancreatology; 2016; 16(6):1028-1036. PubMed ID: 27681503
[TBL] [Abstract][Full Text] [Related]
45. Pancreatic mucinous cystic neoplasm in a male patient.
Casadei R; Pezzilli R; Calculli L; Santini D; Taffurelli G; Ricci C; D'Ambra M; Minni F
JOP; 2012 Nov; 13(6):687-9. PubMed ID: 23183402
[TBL] [Abstract][Full Text] [Related]
46. Colloid (mucinous noncystic) carcinoma of the pancreas.
Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
[TBL] [Abstract][Full Text] [Related]
47. Value of inhibin in the identification of granulosa cell tumors of the ovary.
Hildebrandt RH; Rouse RV; Longacre TA
Hum Pathol; 1997 Dec; 28(12):1387-95. PubMed ID: 9416696
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
[TBL] [Abstract][Full Text] [Related]
49. Cytohistological diagnosis of pancreatic serous cystadenoma: a multimodal approach.
Steel M; Rao S; Ho J; Donnellan F; Yang HM; Schaeffer DF
J Clin Pathol; 2019 Sep; 72(9):615-621. PubMed ID: 31235542
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory role of prohibitin in human ovarian epithelial cancer.
Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX
Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933
[TBL] [Abstract][Full Text] [Related]
51. Mucinous cystic neoplasm of the pancreas with ovarian-type stroma arising in the head of the pancreas: case report and review of the literature.
Murakami Y; Uemura K; Morifuji M; Hayashidani Y; Sudo T; Sueda T
Dig Dis Sci; 2006 Mar; 51(3):629-32. PubMed ID: 16614979
[No Abstract] [Full Text] [Related]
52. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
Yeh TS; Jan YY; Chiu CT; Ho YB; Chen TC; Lee KF; Chan KM; Hsu JC; Hwang TL; Chen MF
Gut; 2002 Nov; 51(5):712-6. PubMed ID: 12377812
[TBL] [Abstract][Full Text] [Related]
53. Mucinous cystadenoma of the ovary with functioning stroma and virilization in pregnancy: a case report and review of the literature.
Antoniou N; Varras M; Akrivis Ch; Demou A; Bellou A; Stefanaki S
Clin Exp Obstet Gynecol; 2003; 30(4):248-52. PubMed ID: 14664425
[TBL] [Abstract][Full Text] [Related]
54. Definition of MCN (mucinous cystic neoplasm of the pancreas) and a proposal for a new concept of MRN or MSN (mucinous round or spherical neoplasm).
Kimura W; Nomura T; Mizutani M; Ma J; Hirai I; Fuse A
Hepatogastroenterology; 2007; 54(79):1954-6. PubMed ID: 18251136
[TBL] [Abstract][Full Text] [Related]
55. Management of mucinous cystic neoplasms of the pancreas.
Testini M; Gurrado A; Lissidini G; Venezia P; Greco L; Piccinni G
World J Gastroenterol; 2010 Dec; 16(45):5682-92. PubMed ID: 21128317
[TBL] [Abstract][Full Text] [Related]
56. Fine-needle aspirations of pancreatic serous cystadenomas: improving diagnostic yield with cell blocks and α-inhibin immunohistochemistry.
Salomao M; Remotti H; Allendorf JD; Poneros JM; Sethi A; Gonda TA; Saqi A
Cancer Cytopathol; 2014 Jan; 122(1):33-9. PubMed ID: 23939868
[TBL] [Abstract][Full Text] [Related]
57. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors.
Choi YL; Kim HS; Ahn G
Arch Pathol Lab Med; 2000 Apr; 124(4):563-9. PubMed ID: 10747314
[TBL] [Abstract][Full Text] [Related]
58. Cystic tumors of the pancreas: imaging and management.
Dewhurst CE; Mortele KJ
Radiol Clin North Am; 2012 May; 50(3):467-86. PubMed ID: 22560692
[TBL] [Abstract][Full Text] [Related]
59. Pathologic T1 and T2 encapsulated invasive carcinomas arising from mucinous cystic neoplasms of the pancreas have favorable prognosis and might be treated conservatively.
Liang H; Xie W; Lin X; Wang T; Xie J; Wang C; Xiao SY; Guo Y
J Pathol Clin Res; 2021 Sep; 7(5):507-516. PubMed ID: 34062050
[TBL] [Abstract][Full Text] [Related]
60. The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma.
Westerhoff M; Tretiakova M; Hart J; Gwin K; Liu X; Zhou M; Yeh MM; Antic T
Hum Pathol; 2014 May; 45(5):1010-4. PubMed ID: 24746205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
